Universal Pulse Oximetry Screening for Early Detection of Critical Congenital Heart Disease.
Critical congenital heart disease (CCHD) is a major cause of infant death and morbidity worldwide. An early diagnosis and timely intervention can significantly reduce the likelihood of an adverse outcome. However, studies from the United States and other developed countries have shown that as many as 30%-50% of infants with CCHD are discharged after birth without being identified. This diagnostic gap is likely to be even higher in low-resource countries. Several large randomized trials have shown that the use of universal pulse-oximetry screening (POS) at the time of discharge from birth hospital can help in early diagnosis of these infants. The objective of this review is to share data to show that the use of POS for early detection of CCHD meets the criteria necessary for inclusion to the universal newborn screening panel and could be adopted worldwide.
Associate Chair, Visiting Professor of Pediatrics, Department of Pediatrics, University of Illinois, Children's Hospital of Illinois, Peoria, IL, USA.
Praveen
P
Kumar
critical congenital heart disease; newborn; pulse-oximetry screening